Recent patterns in shared decision making for prostate-specific antigen testing in the United States

Annals of Family Medicine

Volumn 16, Issue 2, 2018, Pages 139-144

  Fedewa, Stacey A ^a   Gansler, Ted ^a   Smith, Robert ^a   Sauer, Ann Goding ^a   Wender, Richard ^a   Brawley, Otis W ^a   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

Decision making; Early detection of cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; BLOOD; CROSS-SECTIONAL STUDY; DECISION MAKING; EARLY CANCER DIAGNOSIS; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; PROCEDURES; PROSTATE TUMOR; QUESTIONNAIRE; RETROSPECTIVE STUDY; STATISTICAL MODEL; TRENDS; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DECISION MAKING; EARLY DETECTION OF CANCER; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 85043784126     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.2200     Document Type: Article

References (35)

1. Moyer VA; US Preventive Services Task Force. Screening for prostate cancer:U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-134.
2. US Preventive Services Task Force. Draft recommendation statement, prostate cancer:screening. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementDraft/prostate-cancer-screening1. Published 2017. Accessed Apr 11, 2017.
3. Wolf AM, Wender RC, Etzioni RB, et al;American Cancer Society Prostate Cancer Advisory Committee. American Cancer Society guideline for the early detection of prostate cancer:update 2010. CA Cancer J Clin. 2010;60(2):70-98.
4. Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer:AUA Guideline. J Urol. 2013;190(2):419-426.
5. Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P;Clini-cal Guidelines Committee of the American College of Physicians. Screening for prostate cancer:a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2013;158(10):761-769.
6. US Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(3):185-191.
7. Kane HL, Halpern MT, Squiers LB, Treiman KA, McCormack LA. Implementing and evaluating shared decision making in oncology practice. CA Cancer J Clin. 2014;64(6):377-388.
8. Han PK, Kobrin S, Breen N, et al. National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med. 2013;11(4):306-314.
9. Leyva B, Persoskie A, Ottenbacher A, et al. Do men receive information required for shared decision making about PSA testing? Results from a National Survey. J Cancer Educ. 2016;31(4):693-701.
10. Hoffman RM, Couper MP, Zikmund-Fisher BJ, et al. Prostate cancer screening decisions:results from the National Survey of Medical Decisions (DECISIONS study). Arch Intern Med. 2009;169(17): 1611-1618.
11. Han PK, Coates RJ, Uhler RJ, Breen N. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000. Am J Prev Med. 2006;30(5):394-404.
12. Leader A, Daskalakis C, Braddock CH III, et al. Measuring informed decision making about prostate cancer screening in primary care. Med Decis Making. 2012;32(2):327-336.
13. Feng B, Srinivasan M, Hoffman JR, et al. Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits. Ann Fam Med. 2013;11(4):315-323.
14. Jemal A, Fedewa SA, Ma J, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA. 2015;314(19):2054-2061.
15. US Department of Health and Human Services. National Health Interview Survey, Survey Description. Hyattsville, Maryland:National Center for Health Statistics;2016.
16. National Center for Health Statistics, Division of Health Interview Statistics. National health interview survey;questionnaires, datasets, and related documentation. http://www.cdc.gov/nchs/nhis/nhis_questionnaires.htm. Accessed Dec 1, 2014.
17. Bieler GS, Brown GG, Williams RL, Brogan DJ. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol. 2010;171(5):618-623.
18. Schröder FH, Hugosson J, Roobol MJ, et al;ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320-1328.
19. Andriole GL, Crawford ED, Grubb RL III, et al;PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310-1319.
20. Ablin RJ. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening—point. Cancer Epidemiol Biomarkers Prev. 2012;21(3):391-394.
21. Brett AS, Ablin RJ. Prostate-cancer screening—what the U.S. Preventive Services Task Force left out. N Engl J Med. 2011;365(21): 1949-1951.
22. Prabhu V, Lee T, Loeb S, et al. Twitter response to the United States Preventive Services Task Force recommendations against screening with prostate-specific antigen. BJU Int. 2015;116(1):65-71.
23. Taylor KL, Williams RM, Davis K, et al. Decision making in prostate cancer screening using decision aids vs usual care:a randomized clinical trial. JAMA Intern Med. 2013;173(18):1704-1712.
24. Volk RJ, Hawley ST, Kneuper S, et al. Trials of decision aids for prostate cancer screening:a systematic review. Am J Prev Med. 2007; 33(5):428-434.
25. Davis K, Haisfield L, Dorfman C, Krist A, Taylor KL. Physicians’ attitudes about shared decision making for prostate cancer screening. Fam Med. 2011;43(4):260-266.
26. Friedberg MW, Van Busum K, Wexler R, Bowen M, Schneider EC. A demonstration of shared decision making in primary care highlights barriers to adoption and potential remedies. Health Aff (Millwood). 2013;32(2):268-275.
27. Gravel K, Légaré F, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice:a systematic review of health professionals’ perceptions. Implement Sci. 2006;1:16.
28. Elwyn G, Scholl I, Tietbohl C, et al. “Many miles to go …”:a systematic review of the implementation of patient decision support interventions into routine clinical practice. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S14.
29. Sepucha KR, Simmons LH, Barry MJ, Edgman-Levitan S, Licurse AM, Chaguturu SK. Ten years, forty decision aids, and thousands of patient uses:shared decision making at Massachusetts General Hospital. Health Aff (Millwood). 2016;35(4):630-636.
30. Volk RJ, Spann SJ, Cass AR, Hawley ST. Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up. Ann Fam Med. 2003;1(1):22-28.
31. Fedewa SAWE, Ward EM, Brawley O, Jemal A. Recent patterns of prostate-specific antigen testing for prostate cancer screening in the United States. JAMA Intern Med. 2017;177(7):1040-1042.
32. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter:what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681-692.
33. Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories:a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(4):748-757.
34. National Health Interview Survey. Cognitive interview evaluaton of the 2015 NHIS Cancer Control Supplement. https://wwwn.cdc.gov/qbank/report/Willson_2014_NCHS_NHIS.pdf. Published 2015. Accessed Feb 2, 2017.
35. Sepucha KR, Scholl I. Measuring shared decision making:a review of constructs, measures, and opportunities for cardiovascular care. Circ Cardiovasc Qual Outcomes. 2014;7(4):620-626.